LOOMIS SAYLES & CO L P - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$8
-11.1%
3010.0%0.00%
Q2 2023$9
-25.0%
301
-10.1%
0.00%
Q1 2023$12
-99.4%
335
+781.6%
0.00%
Q3 2022$2,000
-33.3%
38
-46.5%
0.00%
Q2 2022$3,0000.0%710.0%0.00%
Q1 2022$3,000
-62.5%
71
-68.9%
0.00%
Q3 2021$8,0002280.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders